Cano Health Amends MSP Recovery Stake; Ownership Change Noted

Ticker: MSPRZ · Form: SC 13D/A · Filed: Jan 24, 2024 · CIK: 1802450

Msp Recovery, INC. SC 13D/A Filing Summary
FieldDetail
CompanyMsp Recovery, INC. (MSPRZ)
Form TypeSC 13D/A
Filed DateJan 24, 2024
Risk Levelmedium
Pages4
Reading Time4 min
Key Dollar Amounts$0.0001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: insider-ownership, amendment, institutional-investor

Related Tickers: CANO

TL;DR

**Cano Health just updated its stake in MSP Recovery, signaling a shift in a key investor's position.**

AI Summary

Cano Health, Inc. filed an amended Schedule 13D/A on January 24, 2024, updating its ownership in MSP Recovery, Inc. This amendment, dated January 22, 2024, indicates a change in their beneficial ownership of MSP Recovery's Class A Common Stock. While the filing doesn't specify the exact change in share count or percentage, it signals that Cano Health's stake in MSP Recovery has been adjusted, which could impact MSP Recovery's stock price due to a significant holder's altered position.

Why It Matters

This filing indicates a change in a major holder's position, which can influence investor perception and potentially the stock's liquidity and price.

Risk Assessment

Risk Level: medium — Changes in significant ownership can create uncertainty and volatility for the stock, especially if the change is a reduction.

Analyst Insight

Investors should monitor subsequent filings to understand the exact nature and magnitude of Cano Health's change in ownership, as a significant reduction could signal a lack of confidence, while an increase could be seen as a bullish indicator.

Key Players & Entities

FAQ

What type of securities does Cano Health, Inc. hold in MSP Recovery, Inc.?

Cano Health, Inc. holds Class A Common Stock, par value $0.0001 per share, of MSP Recovery, Inc.

When was the event that required the filing of this amendment?

The date of the event which required the filing of this statement was January 22, 2024.

What is the CUSIP number for MSP Recovery, Inc.'s Class A Common Stock?

The CUSIP number for MSP Recovery, Inc.'s Class A Common Stock is 553745100.

Who is the person authorized to receive notices and communications for Cano Health, Inc. regarding this filing?

David J. Armstrong, Esq., General Counsel for Cano Health, Inc., is authorized to receive notices and communications.

What is the business address of MSP Recovery, Inc.?

The business address of MSP Recovery, Inc. is 2701 Le Jeune Road, Floor 10, Coral Gables, FL 33134.

Filing Stats: 1,085 words · 4 min read · ~4 pages · Grade level 9.7 · Accepted 2024-01-24 17:04:49

Key Financial Figures

Filing Documents

From the Filing

SC 13D/A 1 d79036dsc13da.htm SC 13D/A SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, Florida 33178 Tel: (855) 226-6633 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 22, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.: 553745100 1 NAMES OF REPORTING PERSONS Cano Health, Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 6,125,998 8 SHARED VOTING POWER 0 9 SOLE DISPOSITIVE POWER 6,125,998 10 SHARED DISPOSITIVE POWER 0 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,125,998 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 42.5%(1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO (1) The 6,125,998 shares of Class A common stock of MSP Recovery, Inc. (the Issuer) reported herein represents 4.4% of the Issuers total issued and outstanding voting shares. (See Item 5 of the Schedule 13D.) This Amendment No. 2 ( Amendment No. 2 ) to Schedule 13D relates to the Class A Common Stock, par value $0.0001 per share (the Class A Shares ), of MSP Recovery, Inc., a Delaware corporation (the Issuer ), and amends and supplements the initial statement on Schedule 13D filed by Cano Health, Inc., a Delaware corporation (the Reporting Person ), with the Securities and Exchange Commission ( SEC ) on July 17, 2023, as amended by Amendment No. 1 to the Schedule 13D filed with the SEC on January 12, 2024 (as so amended, the Schedule 13D ). Capitalized terms used but not defined in this Amendment No. 2 shall have the same meanings ascribed to them in the Schedule 13D. Item5. Interest in Securities of the Issuer. Items 5(a)-(c) of the Schedule 13D are hereby amended and restated as follows: (a) and (b) The percentage of beneficial ownership of the Class A Shares reported in this Schedule 13D assumes 14,415,930 Class A Shares outstanding as of November 27, 2023, based on information set forth in the Form S-1/A filed by the Issuer on December 8, 2023 (the Form S-1/A ). As of January 23, 2024, the aggregate number and percentage of Class A Shares beneficially owned by the Reporting Person and, for the Reporting Person, the number of shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition are set forth on rows 7 through 11 and row 13 of the cover page of this Schedule 13D and are incorporated herein by reference. As of January 23, 2024, Cano Health, LLC, an indirect subsidiary of the Reporting Person, directly owns the 6,125,998 Class A Shares reported herein representing approximately 42.5% of the Class A Shares outstanding. The 6,125,998 Class A Shares beneficially owned by the Reporting Person represent approximately 4.4% of the Issuers total outstanding voting shares. The Reporting Persons voting power percentage assumes an aggregate of 138,669,106 shares of Issuer voting stock outstanding, consisting of (x) 14,415,930 Class A Shares outstanding as of November 27, 2023, based on information set forth in the Form S-1/A, and (y) 124,253,176 shares of the Issuers Class

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing